Description

Medtronic is working with the global community to change the way people manage diabetes. Together, we will transform diabetes care by expanding access, integrating care and improving outcomes, so people with diabetes can enjoy greater freedom and better health.

Medtronic Diabetes operates three global business units to serve customers worldwide:

• The Intensive Insulin Management Business Unit: This business unit serves the needs of those with type 1 diabetes and those who use intensive insulin regimens with type 2 diabetes. This business unit is our history and our heritage, and where we have offered a comprehensive approach to improve outcomes and care. We remain committed to innovation so that we can develop an artificial pancreas and close the loop.
• The Non-Intensive Diabetes Therapies Business Unit: This business unit focuses on addressing the needs of patients with type 2 diabetes who do not use intensive insulin regimens and provides solutions along the diabetes care continuum. This team, working together with our partners, people with diabetes, providers, and payers, is focusing on developing products and solutions to improve clinical outcomes and reduce the burden of managing type 2 diabetes.
• The Diabetes Service and Solutions Business Unit: This business unit optimizes clinical outcomes and enhances the customer experience with our therapies. We are focused on innovation in consumables, such as infusion sets and accessories, and in transforming how data is collected, analyzed and presented through our CareLink system. This team addresses broader needs, including patient education, efficiency in care delivery and financial services, to broaden access and enhance the satisfaction of all of our patients.